How many email patterns does Prilenia use?

Prilenia uses 5 known email patterns.

What domain does Prilenia use for work emails?

Prilenia uses prilenia.com for work email addresses.

Most Common Email Formats at Prilenia

Prilenia's most common email format is First.Last@prilenia.com (ex. John.Doe@prilenia.com), used for 88% of prilenia.com addresses. Prilenia uses 4 email patterns.

@prilenia.com

4 patterns

Format	Example	Share of prilenia.com
First.Last@prilenia.comMost common	John.Doe@prilenia.com	88%
FirstLast@prilenia.com	JohnDoe@prilenia.com	5%
First.Middle@prilenia.com	John.Michael@prilenia.com	3%
Last@prilenia.com	Doe@prilenia.com	4%

Frequently Asked Questions

What does Prilenia do?

Prilenia was founded in 2018 and operates in the Biotechnology Research industry, alongside similar companies like Amylyx Pharmaceuticals, Alkermes and Intra-Cellular Therapies. You can visit prilenia.com. Explore Prilenia's company overview page for more information.

What is Prilenia's email address format?

Prilenia's email format typically follows the pattern of First.Last@prilenia.com; this email format is used 88% of the time. Other contacts within LeadIQ's database had email formats such as FirstLast@prilenia.com and First.Middle@prilenia.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Prilenia have currently?

Prilenia has approximately 63 employees as of November 2026. Key team members to contact include Chief Executive Officer: M. H. M., Chief Operating Officer (coo): L. B. H. and Head Of Corporate Communications: R. C. For more team information and contact data, explore Prilenia's employee directory with LeadIQ.

Prilenia Email Format

Q: What is Prilenia's email address format?

Prilenia's email format typically follows the pattern of ${fn}.${ln}. Other email formats include ${fn}${ln} and ${fn}.${mn}.

Biotechnology ResearchTel Aviv, Israel51-200 Employees

Prilenia is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative and neurodevelopmental disorders. Its lead candidate, pridopidine, is an oral, first-in-class drug with an established safety profile and potential across multiple movement disorders and neurodegenerative diseases affecting adults and children. The company is led by Dr. Michael Hayden, MD, PhD, a biotech veteran who has founded several companies and previously served as President of Global R&D and Chief Scientific Officer at Teva, with a track record of guiding drug programs to approvals. Prilenia operates across multiple locations, including Boston, Massachusetts; Naarden, Netherlands; and Herzliya, Israel. 
Prilenia is advancing pridopidine in Huntington’s disease in the global Phase 3 PROOF-HD trial and in ALS in the Phase 2/3 HEALEY platform trial. Recent leadership appointments during 2024 reflect ongoing organizational development.

Most Common Email Formats at Prilenia

@prilenia.com

Need a specific person's email?

Frequently Asked Questions

What does Prilenia do?

What is Prilenia's email address format?

How many employees does Prilenia have currently?

Prilenia Email Format

Ready to create more pipeline?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Most Common Email Formats at Prilenia

@prilenia.com

Need a specific person's email?

Frequently Asked Questions

What does Prilenia do?

What is Prilenia's email address format?

How many employees does Prilenia have currently?

Prilenia Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.